LSL Pharma Group Engages Paradox as Investor Relations Services Provider
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma...
News
Applied UV to Introduce Airocide® Pro+ Air Food Preservation Solution Designed to Control Ethylene Levels and Extend Shelf Life at the Global Produce & Floral Show, Together With Canon Virginia, a Subsidiary of Canon U.S.A.
Applied UV, Inc. Airocide® Pro+ Applications Across the Food Supply and Logistics ChainRemoving Ethylene, a Gas Produced Naturally, is Critical...
Immunocore announces upcoming presentation and posters at ESMO 2023
Immunocore announces upcoming presentation and posters at ESMO 2023 Long-term survival data for KIMMTRAK in previously untreated patients with metastatic...
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
LONDON and SALT LAKE CITY, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company...
The Ensign Group Acquires Skilled Nursing Facility in Kansas
SAN JUAN CAPISTRANO, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group...
Janssen Submits Application to the European Medicines Agency for RYBREVANT®▼ (amivantamab) in Combination with Chemotherapy for the First-Line Treatment of Adult Patients with Advanced Non-Small Cell Lung Cancer with Activating EGFR Exon 20 Insertion Mutations
Type II Extension of Indication Application is supported by data from PAPILLON, the first randomised Phase 3 study to read...
Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023
LONDON and RALEIGH, N.C., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”),...
Spexis to host business update conference call on October 9, 2023
ALLSCHWIL, Switzerland, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics...
Sequana Medical announces Extraordinary General Meeting of Shareholders on 10 November 2023
PRESS RELEASEREGULATED INFORMATION06 October 2023, 07:00 am CEST Ghent, Belgium – 06 October 2023 – Sequana Medical NV (Euronext...
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0)...
Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a...
Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction in plasma...
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
Monthly information regarding the total number of voting rights and total number...
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three...
AMN Healthcare to Hold Third Quarter 2023 Earnings Conference Call on Thursday, November 2, 2023
DALLAS, Oct. 05, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss...
Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA) (the “Company” or “Kineta”), a clinical-stage biotechnology company focused...
ABIONYX Pharma Completes a Capital Increase in Favor of Categories of Persons
Financial visibility extended to Q1 2025 without drawing on the equity-linked financing facilityTOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX...
Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / MindBio Therapeutics Corp. (CSE:MBIO);(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to...
Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction
VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / Verisante Technology, Inc. (TSXV:VER.H) (the "Company") previously announced on September 7,...